TW202229277A - 用於治療隱孢子蟲病之化合物及組成物 - Google Patents

用於治療隱孢子蟲病之化合物及組成物 Download PDF

Info

Publication number
TW202229277A
TW202229277A TW110137677A TW110137677A TW202229277A TW 202229277 A TW202229277 A TW 202229277A TW 110137677 A TW110137677 A TW 110137677A TW 110137677 A TW110137677 A TW 110137677A TW 202229277 A TW202229277 A TW 202229277A
Authority
TW
Taiwan
Prior art keywords
pyridine
methyl
compound
alkyl
methylpyrazolo
Prior art date
Application number
TW110137677A
Other languages
English (en)
Chinese (zh)
Inventor
約瑟夫 麥可 楊
麥可 羅伯特 圖納
路培超
Original Assignee
瑞士商諾華公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑞士商諾華公司 filed Critical 瑞士商諾華公司
Publication of TW202229277A publication Critical patent/TW202229277A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW110137677A 2020-10-14 2021-10-12 用於治療隱孢子蟲病之化合物及組成物 TW202229277A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063091866P 2020-10-14 2020-10-14
US63/091,866 2020-10-14

Publications (1)

Publication Number Publication Date
TW202229277A true TW202229277A (zh) 2022-08-01

Family

ID=78302850

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110137677A TW202229277A (zh) 2020-10-14 2021-10-12 用於治療隱孢子蟲病之化合物及組成物

Country Status (12)

Country Link
US (1) US12018024B2 (https=)
EP (1) EP4229055B1 (https=)
JP (1) JP7791184B2 (https=)
CN (1) CN116368137A (https=)
AR (1) AR123766A1 (https=)
AU (1) AU2021362803A1 (https=)
CA (1) CA3197199A1 (https=)
MX (1) MX2023004435A (https=)
PY (1) PY2189412A (https=)
TW (1) TW202229277A (https=)
UY (1) UY39466A (https=)
WO (1) WO2022079616A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR132352A1 (es) * 2023-04-13 2025-06-18 Syngenta Crop Protection Ag Derivados de imidazo[1,2-a]pirazina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2925757T (lt) 2012-11-19 2017-12-27 Novartis Ag Junginiai ir kompozicijos, skirti parazitinių ligų gydymui
CN108495853A (zh) * 2016-01-21 2018-09-04 诺华股份有限公司 用于治疗隐孢子虫病的化合物和组合物
GB201700692D0 (en) 2017-01-16 2017-03-01 Salvensis Novel compounds and their use in the treatment of schistosomiasis

Also Published As

Publication number Publication date
AR123766A1 (es) 2023-01-11
MX2023004435A (es) 2023-05-08
UY39466A (es) 2022-05-31
CN116368137A (zh) 2023-06-30
WO2022079616A1 (en) 2022-04-21
US20220112189A1 (en) 2022-04-14
PY2189412A (es) 2022-05-17
US12018024B2 (en) 2024-06-25
CA3197199A1 (en) 2022-04-21
JP2023545452A (ja) 2023-10-30
EP4229055A1 (en) 2023-08-23
EP4229055B1 (en) 2026-03-04
JP7791184B2 (ja) 2025-12-23
AU2021362803A1 (en) 2023-06-01

Similar Documents

Publication Publication Date Title
TWI808067B (zh) 作為ehmt2抑制劑之胺取代的雜環化合物及其使用方法
AU2015335694B2 (en) Indole carboxamide compounds useful as kinase inhibitors
JP6063870B2 (ja) RORγ活性の阻害用のN−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療
TWI440639B (zh) 作為trpv1調節劑之四氫-嘧啶并氮呯類
DK3013814T3 (en) SUBSTITUTED TETRAHYDROCARBAZOL AND CARBAZOLCARBOXAMIDE COMPOUNDS WHICH CAN BE USED AS KINase INHIBITORS
CN105473573B (zh) 用作激酶抑制剂的咔唑甲酰胺化合物
CA2890981A1 (en) Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn.alpha. responses
EP2920177A1 (en) Compounds and compositions for the treatment of parasitic diseases
JP2006520796A (ja) ヒストンデアセチラーゼインヒビター
TW201307284A (zh) 脂肪酸醯胺水解酶(faah)抑制劑
TW201429967A (zh) 用於治療寄生蟲疾病之化合物及組合物
US20240199535A1 (en) Deuterated dhodh inhibitors
TW202237600A (zh) 雙環衍生物
WO2009085256A1 (en) Anti-hiv compounds
MX2015002270A (es) Derivados aminopirimidinicos 4,6-disustituidos novedosos.
TW201728325A (zh) 治療隱孢子蟲病之化合物及組合物
JP2019509272A (ja) 脊髄性筋萎縮症の治療のための併用療法
AU2006292429A1 (en) Carbazole derivatives
KR102417483B1 (ko) 융합된 아자헤테로사이클릭 화합물 및 ampa 수용체 조절제로서의 이들의 용도
MX2007015705A (es) Derivados biciclicos como inhibidores de la cinasa p38.
TW202229277A (zh) 用於治療隱孢子蟲病之化合物及組成物
TWI922476B (zh) 胺基嘧啶酮衍生物
TWI392677B (zh) 抗病毒化合物、其製備方法及用途
HK40130359A (zh) 犬janus激酶抑制剂及其用途
CA3250182A1 (en) TRYPTANTHRINE DERIVATIVES AND THEIR USES